The effectiveness of CFTR-interfering drugs in preventing cystogenesis has also been demonstrated using ADPKD mouse models (Blazer-Yost et al., 2010; Yang et al., 2008; Yuajit et al., 2014). Here, CFTR is linked to autosomal dominant polycystic kidney disease.